Patients who use cannabis for medical purposes speak to the Task Force on Marijuana Legalization and Regulation
Experiences of medical cannabis patients provide the Task Force with the insight necessary to prioritize patients’ needs.
Patients who use cannabis for medical purposes had the opportunity to directly address the federal government’s Task Force on Marijuana Legalization and Regulation about their issues and concerns as the Task Force develops recommendations for the government’s planned major changes to Canadian laws about cannabis.
Joint submission to the Task Force on the Legalization and Regulation of Marijuana
The needs of patients who use cannabis for medical purposes must remain at the heart of policy reform as the federal government moves ahead to legalize and regulate cannabis for personal use.
To this end, the Arthritis Society, Canadians for Fair Access to Medical Marijuana and the Canadian AIDS Society developed this submission to the Task Force on the Legalization and Regulation of Marijuana.
Health Canada opens door to home-grown medical cannabis, but leaves key question unanswered
The new medical cannabis access regulations published today by Health Canada support recommendations previously made by The Arthritis Society, along with Canadians for Fair Access to Medical Marijuana (CFAMM), in that they broaden patients’ access to medical cannabis by including the option to grow it at home, with certain restrictions.
Health Canada announces new regulations for accessing medical cannabis
“Home grow” to be an option for some patients, but seeds and plants will be sourced through licensed producers.
What’s missing from the discussion around medical cannabis and legalization?
In an op-ed piece to the Globe and Mail, Janet Yale explains that the current discussions around cannabis and legalization are missing one key consideration: research.
Medical Cannabis Research Roundtable Urges Federal Investment in Research & Clinical Trials
In its final report - "Clearing the Air" [PDF], released in May 2016 - the Medical Cannabis Research Roundtable urges the federal government to invest $25 million over the next five years to address the scarcity of medical research and trials into the health impacts and potential therapeutic benefits of medical cannabis. The Roundtable is a high-level group of physicians, clinicians, patients, health charities, experts and medical researchers.
The Arthritis Society helps patients navigate the confusing world of medical cannabis
The Arthritis Society today marks the beginning of Arthritis Awareness Month by releasing "Medical Cannabis: A Guide to Access". This guide will help people with arthritis understand and navigate the process for accessing medical cannabis to treat arthritis symptoms. (This guide is intended for adults only. The Arthritis Society does not endorse or recommend medical cannabis. This guide has been created for educational purposes to provide information about medical cannabis as a potential treatment option).
Arthritis Society Position Paper on Medical Cannabis
The Arthritis Society calls for more research into the efficacy and safety associated with the use of medical cannabis as a treatment option.
Why I'm deciding to try medical cannabis
Rheumatoid arthritis adjusted the forecast of Rachel Janzen's life. In this first person essay, follow her experiences and see why she is staking hope in medical cannabis to soften her pain.
Dr. Jason McDougall of Dalhousie University, who is embarking on a three-year investigation of medical cannabis, answers your commonly asked questions.
Dr. Danial Schecter, a prescribing physician, describes the new process for accessing medical cannabis in Canada, and discusses the kinds of questions patients should ask their physician when considering medical cannabis to treat their arthritis symptoms.
Dr. Danial Schecter, a prescribing physician, discusses the kinds of questions patients should ask a licensed producer when considering medical cannabis to treat their arthritis symptoms, and what to expect if and when they begin treatment.
Rachel Janzen describes living with the pain of rheumatoid arthritis, and the challenge of finding a treatment that will help manage her pain without serious side effects.
Rachel Janzen talks about why she's turned to medical cannabis to help treat her rheumatoid arthritis symptoms.
Canadian Arthritis Patient Alliance position paper
Canadians living with arthritis continue to join our call for more research into the safety and efficacy of medical cannabis. The Canadian Arthritis Patient Alliance issued their position paper on the subject.
View the Position Paper
The Arthritis Society thanks the following sponsors for their support of our medical cannabis education and research initiatives: